608 related articles for article (PubMed ID: 25598272)
1. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
2. Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour development.
Chemes H; Muzulin PM; Venara MC; Mulhmann Mdel C; Martínez M; Gamboni M
APMIS; 2003 Jan; 111(1):12-23; discussion 23-4. PubMed ID: 12760349
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype.
Słowikowska-Hilczer J; Romer TE; Kula K
J Androl; 2003; 24(2):270-8. PubMed ID: 12634315
[TBL] [Abstract][Full Text] [Related]
4. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
5. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
[TBL] [Abstract][Full Text] [Related]
6. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
[TBL] [Abstract][Full Text] [Related]
7. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ.
Jørgensen A; Nielsen JE; Almstrup K; Toft BG; Petersen BL; Rajpert-De Meyts E
J Pathol; 2013 Mar; 229(4):588-98. PubMed ID: 23303528
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
11. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.
Mayer F; Stoop H; Sen S; Bokemeyer C; Oosterhuis JW; Looijenga LH
Oncogene; 2003 Jun; 22(25):3859-66. PubMed ID: 12813459
[TBL] [Abstract][Full Text] [Related]
13. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
14. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
15. Do environmental factors play a role in the aetiology of carcinoma in situ testis and the testicular dysgenesis syndrome?
Sonne SB; Hoei-Hansen CE; Fisher JS; Leffers H; Rajpert-de Meyts E; Skakkebaek NE
Verh Dtsch Ges Pathol; 2004; 88():144-51. PubMed ID: 16892545
[TBL] [Abstract][Full Text] [Related]
16. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
Lawaetz AC; Almstrup K
Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
[TBL] [Abstract][Full Text] [Related]
17. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
18. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of neoplastic changes in germ cells as a developmental aspect].
Słowikowska-Hilczer J
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):37-42. PubMed ID: 17493405
[TBL] [Abstract][Full Text] [Related]
20. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes.
Cools M; van Aerde K; Kersemaekers AM; Boter M; Drop SL; Wolffenbuttel KP; Steyerberg EW; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2005 Sep; 90(9):5295-303. PubMed ID: 15998778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
